StockData
Integrated BioPharma Inc logo

Integrated BioPharma Inc (INBP) stock

INBPOTCPharmaceutical PreparationsFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$0.18+0.00 (0.00%)

Close on Oct 19, 2026Market cap $5.59MP/E –Yield –

Integrated BioPharma operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Integrated BioPharma's operating income for the twelve months ending Jun 30, 2026 was -$2.71M, down 233.9% year over year. For fiscal 2026 it was -$2.71M, down 233.9% from the year before. The highest annual figure on record is $5.78M in fiscal 2021.

Annual operating income

PeriodPeriod endValueChange
FY2026Jun 30, 2026-$2.71M-233.9%
FY2025Jun 30, 2025$2.02M+704.8%
FY2024Jun 30, 2024$251.00K+109.2%
FY2023Jun 30, 2023$120.00K-95.6%
FY2022Jun 30, 2022$2.75M-52.5%
FY2021Jun 30, 2021$5.78M+77.5%
FY2020Jun 30, 2020$3.26M+20.5%
FY2019Jun 30, 2019$2.70M+59.6%
FY2018Jun 30, 2018$1.69M-46.8%
FY2017Jun 30, 2017$3.19M+50.8%
FY2016Jun 30, 2016$2.11M+126.6%
FY2015Jun 30, 2015$933.00K-31.0%
FY2014Jun 30, 2014$1.35M+21.1%
FY2013Jun 30, 2013$1.12M–
FY2012Jun 30, 2012-$506.00K–
FY2011Jun 30, 2011-$362.00K–

Quarterly operating income

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ2 2026Jun 30, 2026-$869.00K-247.5%
Q3 FY2026CQ1 2026Mar 31, 2026-$1.09M-246.8%
Q2 FY2026CQ4 2025Dec 31, 2025-$914.00K-552.5%
Q1 FY2026CQ3 2025Sep 30, 2025$163.00K-66.7%
Q4 FY2025CQ2 2025Jun 30, 2025$589.00K+46.5%
Q3 FY2025CQ1 2025Mar 31, 2025$739.00K+108.2%
Q2 FY2025CQ4 2024Dec 31, 2024$202.00K–
Q1 FY2025CQ3 2024Sep 30, 2024$490.00K–
Q4 FY2024CQ2 2024Jun 30, 2024$402.00K+408.9%
Q3 FY2024CQ1 2024Mar 31, 2024$355.00K+706.8%
Q2 FY2024CQ4 2023Dec 31, 2023-$452.00K–
Q1 FY2024CQ3 2023Sep 30, 2023-$54.00K-280.0%
Q4 FY2023CQ2 2023Jun 30, 2023$79.00K-82.0%
Q3 FY2023CQ1 2023Mar 31, 2023$44.00K-95.6%
Q2 FY2023CQ4 2022Dec 31, 2022-$33.00K-104.5%
Q1 FY2023CQ3 2022Sep 30, 2022$30.00K-94.9%
Q4 FY2022CQ2 2022Jun 30, 2022$438.00K-66.6%
Q3 FY2022CQ1 2022Mar 31, 2022$992.00K-42.3%
Q2 FY2022CQ4 2021Dec 31, 2021$730.00K-41.3%
Q1 FY2022CQ3 2021Sep 30, 2021$585.00K-61.2%
Q4 FY2021CQ2 2021Jun 30, 2021$1.31M+112.3%
Q3 FY2021CQ1 2021Mar 31, 2021$1.72M+79.1%
Q2 FY2021CQ4 2020Dec 31, 2020$1.24M+3.2%
Q1 FY2021CQ3 2020Sep 30, 2020$1.51M+217.0%
Q4 FY2020CQ2 2020Jun 30, 2020$618.00K+7.7%
Q3 FY2020CQ1 2020Mar 31, 2020$960.00K-22.4%
Q2 FY2020CQ4 2019Dec 31, 2019$1.21M+147.4%
Q1 FY2020CQ3 2019Sep 30, 2019$476.00K+17.5%
Q4 FY2019CQ2 2019Jun 30, 2019$574.00K-8.2%
Q3 FY2019CQ1 2019Mar 31, 2019$1.24M+87.4%
Q2 FY2019CQ4 2018Dec 31, 2018$487.00K+146.0%
Q1 FY2019CQ3 2018Sep 30, 2018$405.00K+91.9%
Q4 FY2018CQ2 2018Jun 30, 2018$625.00K-24.7%
Q3 FY2018CQ1 2018Mar 31, 2018$660.00K+53.8%
Q2 FY2018CQ4 2017Dec 31, 2017$198.00K-65.3%
Q1 FY2018CQ3 2017Sep 30, 2017$211.00K-84.5%
Q4 FY2017CQ2 2017Jun 30, 2017$830.00K–
Q3 FY2017CQ1 2017Mar 31, 2017$429.00K–
Q2 FY2017CQ4 2016Dec 31, 2016$570.00K–
Q1 FY2017CQ3 2016Sep 30, 2016$1.36M–

More Integrated BioPharma figures

See a number that looks wrong?